129 related articles for article (PubMed ID: 37318812)
1. Encapsulation of Au(III) Complex Using Lactoferrin Nanoparticles to Combat Glioma.
Zhang J; Fang R; Li Y; Jin J; Yang F; Chen J
Mol Pharm; 2023 Jul; 20(7):3632-3644. PubMed ID: 37318812
[TBL] [Abstract][Full Text] [Related]
2. Developing a Novel Gold(III) Agent to Treat Glioma Based on the Unique Properties of Apoferritin Nanoparticles: Inducing Lethal Autophagy and Apoptosis.
Zhang J; Zhang Z; Jiang M; Li S; Yuan H; Sun H; Yang F; Liang H
J Med Chem; 2020 Nov; 63(22):13695-13708. PubMed ID: 33185442
[TBL] [Abstract][Full Text] [Related]
3. Lactoferrin-modified poly(ethylene glycol)-grafted BSA nanoparticles as a dual-targeting carrier for treating brain gliomas.
Su Z; Xing L; Chen Y; Xu Y; Yang F; Zhang C; Ping Q; Xiao Y
Mol Pharm; 2014 Jun; 11(6):1823-34. PubMed ID: 24779677
[TBL] [Abstract][Full Text] [Related]
4. Glioma Dual-Targeting Nanohybrid Protein Toxin Constructed by Intein-Mediated Site-Specific Ligation for Multistage Booster Delivery.
Chen Y; Zhang M; Jin H; Li D; Xu F; Wu A; Wang J; Huang Y
Theranostics; 2017; 7(14):3489-3503. PubMed ID: 28912890
[TBL] [Abstract][Full Text] [Related]
5. Lactoferrin-coated polysaccharide nanoparticles based on chitosan hydrochloride/hyaluronic acid/PEG for treating brain glioma.
Xu Y; Asghar S; Yang L; Li H; Wang Z; Ping Q; Xiao Y
Carbohydr Polym; 2017 Feb; 157():419-428. PubMed ID: 27987946
[TBL] [Abstract][Full Text] [Related]
6. Facile synthesis of lactoferrin conjugated ultra small large pore silica nanoparticles for the treatment of glioblastoma.
Janjua TI; Ahmed-Cox A; Meka AK; Mansfeld FM; Forgham H; Ignacio RMC; Cao Y; McCarroll JA; Mazzieri R; Kavallaris M; Popat A
Nanoscale; 2021 Oct; 13(40):16909-16922. PubMed ID: 34533167
[TBL] [Abstract][Full Text] [Related]
7. Overcoming blood brain barrier with a dual purpose Temozolomide loaded Lactoferrin nanoparticles for combating glioma (SERP-17-12433).
Kumari S; Ahsan SM; Kumar JM; Kondapi AK; Rao NM
Sci Rep; 2017 Jul; 7(1):6602. PubMed ID: 28747713
[TBL] [Abstract][Full Text] [Related]
8. Antiglioma via regulating oxidative stress and remodeling tumor-associated macrophage using lactoferrin-mediated biomimetic codelivery of simvastatin/fenretinide.
Mo X; Zheng Z; He Y; Zhong H; Kang X; Shi M; Liu T; Jiao Z; Huang Y
J Control Release; 2018 Oct; 287():12-23. PubMed ID: 30096402
[TBL] [Abstract][Full Text] [Related]
9. Co-administration of dual-targeting nanoparticles with penetration enhancement peptide for antiglioblastoma therapy.
Miao D; Jiang M; Liu Z; Gu G; Hu Q; Kang T; Song Q; Yao L; Li W; Gao X; Sun M; Chen J
Mol Pharm; 2014 Jan; 11(1):90-101. PubMed ID: 24295590
[TBL] [Abstract][Full Text] [Related]
10. Lactoferrin functionalized PEG-PLGA nanoparticles of shikonin for brain targeting therapy of glioma.
Li H; Tong Y; Bai L; Ye L; Zhong L; Duan X; Zhu Y
Int J Biol Macromol; 2018 Feb; 107(Pt A):204-211. PubMed ID: 28863897
[TBL] [Abstract][Full Text] [Related]
11. Nuclear and cytoplasmic delivery of lactoferrin in glioma using chitosan nanoparticles: Cellular location dependent-action of lactoferrin.
Tammam SN; Azzazy HME; Lamprecht A
Eur J Pharm Biopharm; 2018 Aug; 129():74-79. PubMed ID: 29802982
[TBL] [Abstract][Full Text] [Related]
12. Dual-Targeting Lactoferrin-Conjugated Polymerized Magnetic Polydiacetylene-Assembled Nanocarriers with Self-Responsive Fluorescence/Magnetic Resonance Imaging for In Vivo Brain Tumor Therapy.
Fang JH; Chiu TL; Huang WC; Lai YH; Hu SH; Chen YY; Chen SY
Adv Healthc Mater; 2016 Mar; 5(6):688-95. PubMed ID: 26820074
[TBL] [Abstract][Full Text] [Related]
13. Antitumor efficacy of Lf modified daunorubicin plus honokiol liposomes in treatment of brain glioma.
Liu S; Zhang SM; Ju RJ; Xiao Y; Wang X; Song XL; Gu LY; Cheng L; Li XT; Chen GR
Eur J Pharm Sci; 2017 Aug; 106():185-197. PubMed ID: 28583810
[TBL] [Abstract][Full Text] [Related]
14. A pH-sensitive hyaluronic acid prodrug modified with lactoferrin for glioma dual-targeted treatment.
Yin Y; Fu C; Li M; Li X; Wang M; He L; Zhang LM; Peng Y
Mater Sci Eng C Mater Biol Appl; 2016 Oct; 67():159-169. PubMed ID: 27287110
[TBL] [Abstract][Full Text] [Related]
15. Peptide-functionalized and high drug loaded novel nanoparticles as dual-targeting drug delivery system for modulated and controlled release of paclitaxel to brain glioma.
Di Mauro PP; Cascante A; Brugada Vilà P; Gómez-Vallejo V; Llop J; Borrós S
Int J Pharm; 2018 Dec; 553(1-2):169-185. PubMed ID: 30321641
[TBL] [Abstract][Full Text] [Related]
16. Natural Brain Penetration Enhancer-Modified Albumin Nanoparticles for Glioma Targeting Delivery.
Liang J; Gao C; Zhu Y; Ling C; Wang Q; Huang Y; Qin J; Wang J; Lu W; Wang J
ACS Appl Mater Interfaces; 2018 Sep; 10(36):30201-30213. PubMed ID: 30113810
[TBL] [Abstract][Full Text] [Related]
17. LDL receptors and their role in targeted therapy for glioma: a review.
Pawar S; Koneru T; McCord E; Tatiparti K; Sau S; Iyer AK
Drug Discov Today; 2021 May; 26(5):1212-1225. PubMed ID: 33609780
[TBL] [Abstract][Full Text] [Related]
18. Targeting delivery of etoposide to inhibit the growth of human glioblastoma multiforme using lactoferrin- and folic acid-grafted poly(lactide-co-glycolide) nanoparticles.
Kuo YC; Chen YC
Int J Pharm; 2015 Feb; 479(1):138-49. PubMed ID: 25560309
[TBL] [Abstract][Full Text] [Related]
19. RVG29-modified docetaxel-loaded nanoparticles for brain-targeted glioma therapy.
Hua H; Zhang X; Mu H; Meng Q; Jiang Y; Wang Y; Lu X; Wang A; Liu S; Zhang Y; Wan Z; Sun K
Int J Pharm; 2018 May; 543(1-2):179-189. PubMed ID: 29555442
[TBL] [Abstract][Full Text] [Related]
20. Mustard-inspired delivery shuttle for enhanced blood-brain barrier penetration and effective drug delivery in glioma therapy.
Wang N; Sun P; Lv M; Tong G; Jin X; Zhu X
Biomater Sci; 2017 May; 5(5):1041-1050. PubMed ID: 28378865
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
